latest news releases from the newsroom
Heimstaden förvärvar bostadbestånd i Malmö
Heimstaden utökar sitt ägande i Malmö genom att avtala om förvärv av Möllekällan
Möllekällan äger idag 15 fastigheter på Möllevången och S:t Knuts Torg, med en
totalyta på 21 300 kvm, bestående av 314 lägenheter och ett mindre antal lokaler
i bottenplan, främst restauranger, caféer och mindre butiker.
Heimstaden har även av Tensor Fastighets AB förvärvat fastigheten Yrket 3 på
Möllevången innehållande 26 lägenheter.
”Med dessa förvärv kompletterar vi vår redan starka närvaro me
Grand View Research
Bioadhesives Market By Source (Plant Based & Animal based), By Application (Packaging & Paper, Construction, Wood, Personal Care, Medical) Is Expected to Reach $2,549.2 Million by 2022: New Report By Grand View Research, Inc.
San Francisco, California, May 27, 2015 (GLOBE NEWSWIRE) -- The global bioadhesives market is expected to
reach USD 2,549.2 million by 2022, according to a new study by
Grand View Research, Inc. Volatile prices of synthetic adhesives on
account of fluctuation in raw material prices is expected to remain
a key driving factor for global bioadhesives market. Government
support to promote the use of natural, environmental friendly
products particularly in North America and Europe is also expected
to have a positive influence on the market growth. Growth of key
end-use industries such as packaging, construction and automotive
particularly in emerging markets of Asia Pacific is also expected
to impact the demand positively. Low shelf life of bioadhesives
compared to synthetic adhesives is expected to remain a key
challenge for market participants.
G1 Therapeutics Announces Positive Phase 1a Data for CDK4/6 Inhibitor G1T28
RESEARCH TRIANGLE PARK, N.C., May 27, 2015 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc., a clinical-stage oncology company, announced today that its lead compound G1T28, a highly potent and selective CDK4/6 inhibitor, demonstrated robust, transient cell-cycle arrest of hematopoietic stem and progenitor cells (HSPCs) in a first-in-human Phase 1a study. The compound was well tolerated with predictable pharmacokinetic (PK) / pharmacodynamic (PD) activity. These data will be presented on Saturday, May 30 in two posters at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting at McCormick Place in Chicago.
Illinois Tool Works
ITW Announces Plans to Webcast Presentation for Deutsche Bank Global Industrials Conference
GLENVIEW, Ill., May 27, 2015 (GLOBE NEWSWIRE) -- Illinois Tool Works Inc. (NYSE:ITW) today announced plans to present at the upcoming Deutsche Bank Global Industrials and Basic Materials Conference being held at the Westin River North in Chicago. ITW's question and answer session featuring Chief Financial Officer Michael Larsen will take place Thursday, June 4, from 11:20AM – 11:55AM CT. A link to the presentation is available at both